The European healthcare technology and medical technology sectors have entered a period of definitive industrial maturity as of early 2026. This era is characterised by a fundamental shift away from the liquidity-fueled exuberance of the early 2020s toward a disciplined, metrics-driven environment where strategic value is defined by clinical utility, regulatory resilience, and technological defensibility. Within this landscape, the role of financial advisory has undergone a r

The Specialist Boutiques: Firms like Nelson Advisors and Clipperton offer highly targeted, domain-specific expertise. They often cater to founder-led exits and specific verticals like Health IT, MedTech, and AI, providing a level of operational empathy and sector nuance that larger firms cannot provide.